Literature DB >> 29076885

Office blood pressure measurement alone often misclassifies treatment status in children with primary hypertension.

Joyce P Samuel1, Cynthia S Bell, Sean A Hebert, Arun Varughese, Joshua A Samuels, Jon E Tyson.   

Abstract

OBJECTIVE: Clinicians frequently rely on office blood pressure (BP) measurements alone to assess hypertension control, despite widespread acceptance of 24-h ambulatory blood pressure monitoring (ABPM) as the reference standard in the initial diagnosis of hypertension. This study was designed to investigate how often the hypertensive status differed between concurrent office BP versus ABPM measurements, and whether any patient-specific characteristics predict the risk for misclassification by office BP. PARTICIPANTS AND METHODS: This study evaluated 42 children with primary hypertension who underwent repeated ambulatory monitoring (190 total recordings) with concurrent office BP measurement as part of their participation in n-of-1 trials.
RESULTS: In nearly 40% of the visits, the treatment status by office measurement was opposite to the status by ambulatory monitoring. Office BP underestimated the ambulatory hypertensive status (masked uncontrolled hypertension) in 25% of visits and overestimated ambulatory BP (white coat effect) in 14% of visits. The difference between office BP and ambulatory monitoring was consistent within patients across repeated visits. Patients whose office measurement underestimated or overestimated the ambulatory BP at the first visit were more likely to show persistent discrepancy at subsequent visits.
CONCLUSION: The underuse of ambulatory monitoring in management decisions of children treated for primary hypertension may result in systematic misclassification of hypertension control.

Entities:  

Mesh:

Year:  2017        PMID: 29076885      PMCID: PMC5679273          DOI: 10.1097/MBP.0000000000000299

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  15 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

3.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

4.  ABPM vs office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients.

Authors:  Jorge R Ferraris; Lidia Ghezzi; Gabriel Waisman; Rafael T Krmar
Journal:  Pediatr Transplant       Date:  2007-02

5.  Validation of the Welch Allyn Spot Vital Signs blood pressure device according to the ANSI/AAMI SP10: 2002. Accuracy and cost-efficiency successfully combined.

Authors:  Bruce S Alpert
Journal:  Blood Press Monit       Date:  2007-10       Impact factor: 1.444

6.  Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure.

Authors:  Elke Wühl; Charlotte Hadtstein; Otto Mehls; Franz Schaefer
Journal:  Pediatr Res       Date:  2003-11-19       Impact factor: 3.756

7.  Utility of ambulatory blood pressure monitoring in the evaluation of elevated clinic blood pressures in children.

Authors:  Susan M Halbach; Robin Hamman; Karyn Yonekawa; Coral Hanevold
Journal:  J Am Soc Hypertens       Date:  2016-03-03

8.  Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association.

Authors:  Joseph T Flynn; Stephen R Daniels; Laura L Hayman; David M Maahs; Brian W McCrindle; Mark Mitsnefes; Justin P Zachariah; Elaine M Urbina
Journal:  Hypertension       Date:  2014-03-03       Impact factor: 10.190

9.  Accuracy of the Spacelabs 90217 ambulatory blood pressure monitor in a pediatric population.

Authors:  Karen M Redwine; Laura P James; MaryAnn O'Riordan; Janice E Sullivan; Jeffrey L Blumer
Journal:  Blood Press Monit       Date:  2015-10       Impact factor: 1.444

10.  Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial.

Authors:  Martin G Myers; Marshall Godwin; Martin Dawes; Alexander Kiss; Sheldon W Tobe; F Curry Grant; Janusz Kaczorowski
Journal:  BMJ       Date:  2011-02-07
View more
  3 in total

1.  Treating Hypertension in Children With n-of-1 Trials.

Authors:  Joyce P Samuel; Jon E Tyson; Charles Green; Cynthia S Bell; Claudia Pedroza; Don Molony; Joshua Samuels
Journal:  Pediatrics       Date:  2019-03-06       Impact factor: 7.124

Review 2.  Ambulatory Blood Pressure Monitoring in Pediatrics.

Authors:  Sonali S Patel; Stephen R Daniels
Journal:  Curr Hypertens Rep       Date:  2019-07-26       Impact factor: 5.369

3.  Re-evaluating hypertension in children according to different guidelines: a single-center study.

Authors:  Cemaliye Basaran; Belde Kasap Demir; Mustafa Agah Tekindal; Gokcen Erfidan; Ozgur Ozdemir Simsek; Secil Arslansoyu Camlar; Caner Alparslan; Demet Alaygut; Fatma Mutlubas; Ferhan Elmali
Journal:  Hypertens Res       Date:  2022-04-01       Impact factor: 3.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.